US EditionPfizer Wins Obesity Drug Battle, with Assist by Trump’s FTC
The US Federal Trade Commission blocked Novo Nordisk's $10 billion bid, leading Metsera's board to accept Pfizer's offer amid a competitive obesity drug market valued at $100 billion by 2030.
5 Articles
5 Articles
Havasu News
Greater Milwaukee TodayPfizer wins obesity drug battle, with assist by Trump’s FTC
Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he learned he’d finally claimed his prize.
Pfizer Wins Obesity Drug Prize, With Trump Administration Assist
Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he learned he’d finally claimed his prize.
Pfizer wins obesity drug prize, with Trump administration assist
Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he learned he’d finally claimed his prize.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
